Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · IEX Real-Time Price · USD
38.73
-1.27 (-3.18%)
At close: Jul 2, 2024, 4:00 PM
39.90
+1.17 (3.02%)
After-hours: Jul 2, 2024, 6:16 PM EDT
Structure Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for GPCR stock have an average target of 82.17, with a low estimate of 65 and a high estimate of 100. The average target predicts an increase of 112.16% from the current stock price of 38.73.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GPCR stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 3 | 4 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 4 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +67.83% | Jul 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +67.83% | Jun 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +67.83% | Jun 17, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $83 → $100 | Buy | Maintains | $83 → $100 | +158.20% | Jun 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +67.83% | Jun 3, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
56.67M
EPS This Year
-0.94
from -2.43
EPS Next Year
-0.82
from -0.94
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 525.0M | n/a | 156.2M | 209.5M |
| Avg | n/a | 56.7M | n/a | 30.4M | 50.9M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 590.1% |
| Avg | - | - | - | - | 67.6% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.87 | 2.60 | -1.20 | -1.04 | -1.07 |
| Avg | -0.94 | -0.82 | -1.51 | -1.68 | -1.12 |
| Low | -1.08 | -1.57 | -1.78 | -2.29 | -1.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.